High-Beta Risk Remains Top-Performing Equity Factor In 2025

As the trading year heads into its final weeks, so-called high-beta shares remain firmly in the lead for US equity risk factors in 2025, based on a set of ETFs through Tuesday’s close (Dec…SPHB’s bull run this year leaves the rest of the factor field in the dust…Meanwhile, sm…
As the trading year heads into its final weeks, so-called high-beta shares remain firmly in the lead for US equity risk factors in 2025, based on a set of ETFs through Tuesday’s close (Dec. 2).
The year-to-date performance for the Invesco S&P 500 High Beta ETF (SPHB) is still well ahead of the rest of the field and the stock market overall, based on the SPDR S&P 500 ETF (SPY). As of yesterday’s close, SPHB’s total return is a sizzling 29.4% vs. SPY’s 17.3%.

SPHB’s bull run this year leaves the rest of the factor field in the dust. The next-best performer: large-cap growth (IVW), which is up 21.9%.
The key takeaway: high risk has paid off in 2025, by a wide margin. SPHB’s portfolio tracks an index that targets a subset of the S&P 500 based on the 100 stocks with the highest sensitivity to market movements, or beta, over the past 12 months via quarterly rebalancing.
Meanwhile, small-cap stocks remain laggards in the factor horse race this year. The weakest of the weak: small-cap growth (IJT), which is up a mild 5.4% year to date.
But hope springs eternal, still, for small caps. A Bloomberg report this week notes: “Traders are placing bullish bets on small-cap stocks even though they have struggled to outperform their larger cohort over the past year.”
Christopher Jacobson, Susquehanna International Group’s co-head of derivatives strategy, outlines the reasoning: “After getting hit in response to more hawkish rate cut expectations, the small caps have been a primary beneficiary of the more recent dovish tilt,” he wrote in a note to clients. 
Author: James Picerno